Your browser doesn't support javascript.
loading
High frequency and poor prognosis of late childhood BCR-ABL-positive and MLL-AF4-positive ALL define the need for advanced molecular diagnostics and improved therapeutic strategies in pediatric B-ALL in Pakistan.
Iqbal, Zafar; Akhtar, Tanveer; Awan, Tashfin; Aleem, Aamer; Sabir, Noreen; Rasool, Mahmood; Absar, Muhammad; Akram, Afia M; Shammas, Masood A; Shah, Ijaz H; Khalid, Muhammad; Taj, Abid S; Jameel, Abid; Alanazi, Abdullah; Gill, Ammara T; Hashmi, Jamil Amjad; Hussain, Akhtar; Sabar, Muhammad Farooq; Khalid, Ahmad M; Qazi, Mehmood Hussain; Karim, Sajjad; Siddiqi, Muhammad Hassan; Mahmood, Aamir; Iqbal, Mudassar; Saeed, Anjum; Irfan, Muhammad Imran.
Afiliación
  • Iqbal Z; Medical Genetics/Hematology and Oncology, CLS, CAMS, King Saud Bin Abdulaziz University for Health Sciences/KAIMRC, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, 11426, Saudi Arabia. drzafar.medgen@yahoo.com.
  • Akhtar T; Hematology Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences/Parasitology Laboratories (HSL), Department of Zoology, University of the Punjab (ZPU), Lahore, Pakistan. drzafar.medgen@yahoo.com.
  • Awan T; Department of Biotechnology, University of Sargodha, Sargodha, Pakistan. drzafar.medgen@yahoo.com.
  • Aleem A; Institute of Molecular Biology and Biotechnology (IMBB), Centre for Research in Molecular Medicine (CRiMM), The University of Lahore, Lahore, Pakistan. drzafar.medgen@yahoo.com.
  • Sabir N; Pakistan Society for Molecular and Clinical Hematology (PSMH) & Hematology Oncology and Pharmacogenetic Engineering Sciences Group (HOPES), Lahore, Pakistan. drzafar.medgen@yahoo.com.
  • Rasool M; Department of Zoology, Faculty of Biological Sciences, University of the Punjab, Lahore, Pakistan.
  • Absar M; Pakistan Society for Molecular and Clinical Hematology, Lahore, Pakistan.
  • Akram AM; Hematology Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences/Parasitology Laboratories (HSL), Department of Zoology, University of the Punjab (ZPU), Lahore, Pakistan.
  • Shammas MA; Pakistan Society for Molecular and Clinical Hematology (PSMH) & Hematology Oncology and Pharmacogenetic Engineering Sciences Group (HOPES), Lahore, Pakistan.
  • Shah IH; Hematology Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences/Parasitology Laboratories (HSL), Department of Zoology, University of the Punjab (ZPU), Lahore, Pakistan.
  • Khalid M; Pakistan Society for Molecular and Clinical Hematology (PSMH) & Hematology Oncology and Pharmacogenetic Engineering Sciences Group (HOPES), Lahore, Pakistan.
  • Taj AS; Division of Hematology/Oncology, Department of Medicine, College of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
  • Jameel A; Hematology Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences/Parasitology Laboratories (HSL), Department of Zoology, University of the Punjab (ZPU), Lahore, Pakistan.
  • Alanazi A; Pakistan Society for Molecular and Clinical Hematology (PSMH) & Hematology Oncology and Pharmacogenetic Engineering Sciences Group (HOPES), Lahore, Pakistan.
  • Gill AT; Centre of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Hashmi JA; Hematology Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences/Parasitology Laboratories (HSL), Department of Zoology, University of the Punjab (ZPU), Lahore, Pakistan.
  • Hussain A; Pakistan Society for Molecular and Clinical Hematology (PSMH) & Hematology Oncology and Pharmacogenetic Engineering Sciences Group (HOPES), Lahore, Pakistan.
  • Sabar MF; Hematology Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences/Parasitology Laboratories (HSL), Department of Zoology, University of the Punjab (ZPU), Lahore, Pakistan.
  • Khalid AM; Pakistan Society for Molecular and Clinical Hematology (PSMH) & Hematology Oncology and Pharmacogenetic Engineering Sciences Group (HOPES), Lahore, Pakistan.
  • Qazi MH; Translational Genomic Instability Program, Harvard (Dana-Farber) Cancer Institute, Harvard Medical School, Harvard University, Boston, MA, USA.
  • Karim S; Department of Oncology, Allied Hospital, Punjab Medical College, Faisalabad, Pakistan.
  • Siddiqi MH; Department of Oncology, Allied Hospital, Punjab Medical College, Faisalabad, Pakistan.
  • Mahmood A; Institute of Radiotherapy and Nuclear Medicine, Peshawar, Pakistan.
  • Iqbal M; Hayatabad Medical Complex, Peshawar, Pakistan.
  • Saeed A; Department of Oncology, Khyber Teaching Hospital, Peshawar, Pakistan.
  • Irfan MI; Medical Genetics/Hematology and Oncology, CLS, CAMS, King Saud Bin Abdulaziz University for Health Sciences/KAIMRC, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, 11426, Saudi Arabia.
Mol Diagn Ther ; 19(5): 277-87, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26266519
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas de Fusión Oncogénica / Proteínas de Fusión bcr-abl / Proteína de la Leucemia Mieloide-Linfoide Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: Mol Diagn Ther Asunto de la revista: BIOLOGIA MOLECULAR / FARMACOLOGIA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2015 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas de Fusión Oncogénica / Proteínas de Fusión bcr-abl / Proteína de la Leucemia Mieloide-Linfoide Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: Mol Diagn Ther Asunto de la revista: BIOLOGIA MOLECULAR / FARMACOLOGIA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2015 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Nueva Zelanda